Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
-$0.14 EPS Expected for AxoGen, Inc (NASDAQ:AXGN) This Quarter
08:56am, Monday, 06'th Apr 2020
Equities research analysts expect that AxoGen, Inc (NASDAQ:AXGN) will announce earnings of ($0.14) per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estima
Advisors Asset Management Inc. Decreases Position in AxoGen, Inc (NASDAQ:AXGN)
08:06am, Sunday, 05'th Apr 2020
Advisors Asset Management Inc. reduced its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 25.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and E
AxoGen, Inc (NASDAQ:AXGN) Expected to Announce Quarterly Sales of $27.05 Million
06:52am, Sunday, 05'th Apr 2020
Wall Street brokerages predict that AxoGen, Inc (NASDAQ:AXGN) will report sales of $27.05 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided est
AxoGen, Inc (NASDAQ:AXGN) Shares Purchased by Bank of America Corp DE
09:14am, Friday, 03'rd Apr 2020
Bank of America Corp DE increased its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 13.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 873,582 shares of the medical equipm
AxoGen, Inc (NASDAQ:AXGN) Short Interest Up 7.0% in March
08:36am, Friday, 03'rd Apr 2020
AxoGen, Inc (NASDAQ:AXGN) was the target of a large growth in short interest in the month of March. As of March 13th, there was short interest totalling 1,625,900 shares, a growth of 7.0% from the Feb
's Top Upgrades, Downgrades For April 2, 2020
01:35pm, Thursday, 02'nd Apr 2020
Upgrades
Credit Suisse changed the rating for MPLX LP (NYSE: MPLX) from Neutral to Outperform. For the fourth quarter, MPLX had an EPS of $0.58, compared to year-...
Morgan Stanley likes Bristol-Myers Squibb in premarket analyst action
11:20am, Thursday, 02'nd Apr 2020
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
AxoGen downgraded to Neutral from Buy at BTIG AXGN
11:13am, Thursday, 02'nd Apr 2020
AxoGen downgraded to Neutral from Buy at BTIG BTIG AXGN
AxoGen downgraded to Neutral from Buy at BTIG AXGN
11:02am, Thursday, 02'nd Apr 2020
AxoGen downgraded to Neutral from Buy at BTIG BTIG AXGN
Analysts Offer Insights on Healthcare Companies: Nevro Crop (NVRO), Inspire Medical Systems (INSP) and AxoGen (AXGN)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO), Inspire Medical Systems (INSP) and AxoGen (AXGN).
Analysts Offer Insights on Healthcare Companies: Nevro Crop (NYSE: NVRO), Inspire Medical Systems (NYSE: INSP) and AxoGen (NASDAQ: AXGN)
10:16am, Thursday, 02'nd Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO – Research
AxoGen suspends previous guidance, RECON study enrollment may get delayed AXGN
09:36am, Wednesday, 01'st Apr 2020
AxoGen suspends previous guidance, RECON study enrollment may get delayed AXGN
AlphaCrest Capital Management LLC Purchases Shares of 11,929 AxoGen, Inc (NASDAQ:AXGN)
10:00am, Tuesday, 24'th Mar 2020
AlphaCrest Capital Management LLC purchased a new stake in AxoGen, Inc (NASDAQ:AXGN) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm
Have Insiders Been Buying AxoGen, Inc. (NASDAQ:AXGN) Shares?
01:08pm, Monday, 23'rd Mar 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
